Our project aims to diagnose and characterise sepsis and ultimately tailor the treatment of sepsis and ARDS using protein profiles. Today, new proteomics methods (such as mass spectrometry) can analyse thousands of proteins at a time from a drop of blood. Our hope is that with protein profiling and artificial intelligence we will be able to diagnose and characterise severe sepsis and ARDS and offer each patient the best treatment.